¡Ya estamos en ! Descubre más
1,004.84 USD
+6.20
0.62%
Al cierre Actualizado 16 oct, 4:00 p.m. EDT
Antes de la apertura del mercado
Después del cierre del mercado
1,004.84
0.00
0%
1 día
0.62%
5 días
5.78%
1 mes
13.25%
3 meses
19.44%
6 meses
15.85%
En lo que va del año
22.03%
1 año
29.58%
5 años
400.42%
10 años
525.48%
 

Acerca de: McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Empleados: 43,000

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 62.3%
Neutral 29.9%
Negativo 7.8%
Neutral
Benzinga
ayer
Jim Cramer: This Health Care Stock Is A ‘Winner', X-Energy Is ‘Losing Too Much Money'
On CNBC's “Mad Money Lightning Round,” Jim Cramer said McKesson Corporation (NYSE:MCK) is a “winner” and it will go much higher. “It is exactly what you buy in this environment," he added.
Jim Cramer: This Health Care Stock Is A ‘Winner', X-Energy Is ‘Losing Too Much Money'
Neutral
Zacks Investment Research
anteayer
McKesson (MCK) Ascends While Market Falls: Some Facts to Note
McKesson (MCK) reached $976.57 at the closing of the latest trading day, reflecting a +1.53% change compared to its last close.
McKesson (MCK) Ascends While Market Falls: Some Facts to Note
Positivo
Zacks Investment Research
hace 3 días
McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?
Positivo
Zacks Investment Research
hace 7 días
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Positivo
Zacks Investment Research
hace 8 días
Here's Why McKesson (MCK) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why McKesson (MCK) is a Strong Growth Stock
Positivo
Zacks Investment Research
hace 8 días
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Neutral
Zacks Investment Research
hace 8 días
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
Negativo
Zacks Investment Research
hace 9 días
Here's Why McKesson (MCK) Fell More Than Broader Market
In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.
Here's Why McKesson (MCK) Fell More Than Broader Market
Positivo
Zacks Investment Research
hace 9 días
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
Positivo
Zacks Investment Research
hace 9 días
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Gráficos de precios implementados con Lightweight Charts™